[go: up one dir, main page]

NO20081043L - Vaksine for fisk - Google Patents

Vaksine for fisk

Info

Publication number
NO20081043L
NO20081043L NO20081043A NO20081043A NO20081043L NO 20081043 L NO20081043 L NO 20081043L NO 20081043 A NO20081043 A NO 20081043A NO 20081043 A NO20081043 A NO 20081043A NO 20081043 L NO20081043 L NO 20081043L
Authority
NO
Norway
Prior art keywords
polypeptide
protein
relates
carrier
nucleic acid
Prior art date
Application number
NO20081043A
Other languages
English (en)
Other versions
NO341881B1 (no
Inventor
Stephane Villoing
Michel Bremont
Coralie Moriette
Monique Le Berre
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of NO20081043L publication Critical patent/NO20081043L/no
Publication of NO341881B1 publication Critical patent/NO341881B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Foreliggende oppfinnelse angår veterinær immunologi, det vil si den immunologiske responsen hos fisk på et virus. Nærmere bestemt tilveiebringer oppfinnelsen en epitop av salmonid alfavirus hvilken epitop er i stand til å indusere en virusnøytraliserende immunrespons. Spesielt angår oppfinnelsen et polypeptid omfattende en bestemt aminosyresekvens, et protein omfattende slikt polypeptid, en bærer omfattende slikt protein og en fremgangsmåte for fremstilling av antistoffer. Videre angår oppfinnelsen en nukleinsyre som koder for slikt polypeptid eller slikt protein og en bærer omfattende en slik nukleinsyre. Oppfinnelsen angår også en vaksine og et diagnostisk sett omfattende et slikt polypeptid, protein, bærer eller nukleinsyre.
NO20081043A 2005-09-16 2008-02-28 Polypeptid, protein, metode for fremstilling av salmonid alphavirus nøytraliserende antistoffer, nukleinsyre, bærer, vaksine og diagnostisk sett NO341881B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05020223 2005-09-16
PCT/EP2006/066401 WO2007031572A1 (en) 2005-09-16 2006-09-15 Fish vaccine

Publications (2)

Publication Number Publication Date
NO20081043L true NO20081043L (no) 2008-04-07
NO341881B1 NO341881B1 (no) 2018-02-12

Family

ID=35064703

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081043A NO341881B1 (no) 2005-09-16 2008-02-28 Polypeptid, protein, metode for fremstilling av salmonid alphavirus nøytraliserende antistoffer, nukleinsyre, bærer, vaksine og diagnostisk sett

Country Status (7)

Country Link
US (2) US7794724B2 (no)
EP (1) EP1928898B1 (no)
JP (1) JP5300479B2 (no)
CA (1) CA2622610C (no)
DK (1) DK179025B1 (no)
NO (1) NO341881B1 (no)
WO (1) WO2007031572A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK179025B1 (da) * 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine
TW200936759A (en) * 2007-12-21 2009-09-01 Intervet Int Bv Fish vaccine
NO346489B1 (no) * 2008-02-08 2022-09-05 Pharmaq As Anvendelse av inaktivert SAV i fremstilling av en vaksine.
NO333242B1 (no) * 2008-02-08 2013-04-15 Pharmaq As Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus
US9366667B2 (en) * 2009-10-02 2016-06-14 The Trustees Of Columbia University In The City Of New York Piscine reovirus diagnostic compositions
CA2796178C (en) 2010-04-21 2021-02-16 Pharmaq As Nucleic acid sequences of fish cardiomyopathy syndrome virus and the use thereof
EP2658866B1 (en) 2010-12-29 2016-05-25 Intervet International B.V. Salmonid alphavirus protein e2
WO2012130723A1 (en) 2011-03-25 2012-10-04 Intervet International B.V. Salmonid alphavirus vaccine
GB201204280D0 (en) * 2012-03-09 2012-04-25 Univ Nordland Methods
EP2895501B1 (en) * 2012-09-17 2017-01-18 Novartis Tiergesundheit AG Salmonid alphavirus and uses thereof
WO2014118385A1 (en) 2013-02-04 2014-08-07 University of Tromsø The use of dna sequences encoding an interferon as vaccine adjuvants
GB2551984B (en) 2016-06-30 2019-01-16 Pharmaq As Fish virus
NO20200827A1 (en) * 2017-12-26 2020-07-14 Univ Chile Vaccine formulation for fish based on lipid nanovesicles,particularly a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs)
US20220080040A1 (en) * 2018-12-21 2022-03-17 Intervet Inc. Serum free intracellular pathogen vaccine
CA3162361A1 (en) * 2019-12-20 2021-06-24 Stephane Villoing Reassorted isa virus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068989T3 (es) 1989-02-04 1995-05-01 Akzo Nobel Nv Tocoles como adyuvante en vacunas.
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
DE69531891D1 (de) 1994-10-18 2003-11-13 Akzo Nobel Nv Virus, welches die Pankreas-Krankheit bei Fischen verursacht
DK1075523T3 (da) * 1998-05-08 2007-12-27 Intervet Int Bv Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
TR200101817T2 (tr) 1998-12-21 2001-12-21 Akzo Nobel N.V. Etkisizleştirilmiş S/Y emülsiyonu katkılı aşılar üretmek için yöntem
FR2839453B1 (fr) 2002-05-07 2007-05-11 Agronomique Inst Nat Rech Utilisation de novirhabdovirus modifies pour l'obtention de vaccins
DK179025B1 (da) * 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine

Also Published As

Publication number Publication date
JP5300479B2 (ja) 2013-09-25
CA2622610A1 (en) 2007-03-22
US20110135659A1 (en) 2011-06-09
EP1928898B1 (en) 2014-08-20
CA2622610C (en) 2017-02-21
US20090162388A1 (en) 2009-06-25
DK179025B1 (da) 2017-08-28
JP2009507509A (ja) 2009-02-26
US8435536B2 (en) 2013-05-07
DK200601181A (da) 2007-03-17
EP1928898A1 (en) 2008-06-11
WO2007031572A1 (en) 2007-03-22
US7794724B2 (en) 2010-09-14
NO341881B1 (no) 2018-02-12

Similar Documents

Publication Publication Date Title
NO20081043L (no) Vaksine for fisk
WO2002080851A3 (en) Chimeric vaccines
NO20063478L (no) Noytraliserende epitopebasert vekstfremmende vaksine
NO20091665L (no) Tumorassosierte antigenderivater fra MAGE-familien, og nuklinsyresekvenser som koder for disse, anvendt for fremstilling av fusjonsproteiner og for vaksinesammensetninger
IL189313A (en) Virus-like particles as virus-paramixo vaccines, a method for their preparation and use
ATE348633T1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
IN2009CN03372A (no)
EP4226938A3 (en) Coronavirus vaccine
EA200701305A1 (ru) Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида
WO2000073430A3 (de) Vakzine gegen konformationsabhängige antigene sowie gegen antigene, die keine oder nicht ausschliesslich proteine oder peptide sind
WO2007098718A8 (es) Antígenos vacunales quiméricos contra el virus de la influenza aviar
WO2023147092A3 (en) Coronavirus vaccine
BRPI0519705A2 (pt) composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo
WO2005081716A3 (en) DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV)
NO20062044L (no) Piscirickettsia salmonis-antigener og anvendelse derav
MX2024006506A (es) Vacunas basadas en vectores virales de metapneumovirus humano.
MX2009007572A (es) Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y.
RU2015106916A (ru) Полипептиды clostridium difficile в виде вакцины
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
WO2009074861A3 (en) Improved vaccine
ZA202403355B (en) Single domain antibodies binding to tetanus neurotoxin
Kumar et al. Outer membrane protein assembly factor YaeT (omp85) and GroEL proteins of Edwardsiella tarda are immunogenic antigens for Labeo rohita (Hamilton)
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
Walczak et al. Method for generation of peptide‐specific igy antibodies directed to Staphylococcus aureus extracellular fibrinogen binding protein epitope
Alizadeh et al. Preparation and purification of polyclonal antibodies against Mycobacterium avium paratuberculosis antigens in rabbit